A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
מצבים רפואיים
Plasmablastic Lymphoma · Ann Arbor Stage I Diffuse Large B-Cell Lymphoma · Ann Arbor Stage II Diffuse Large B-Cell Lymphoma · Ann Arbor Stage III Diffuse Large B-Cell Lymphoma · Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
University of Miami Miller School of Medicine, Miami, Florida, United States
Contact: Principal Investigator (Juan C Ramos, MD)University of Illinois at Chicago, Chicago, Illinois, United States
Contact: Principal Investigator (Paul Rubinstein, MD)Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States
Contact: Principal Investigator (Richard Ambinder, MD)Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Principal Investigator (Ariela Noy, MD)University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States
Contact: Principal Investigator (Christopher Dittus, DO, MPH)The Ohio State University, Columbus, Ohio, United States
Contact: Principal Investigator (Robert Baiocchi, MD, PhD)University of Pennsylvania, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Tanya Latorre, BSN, RN, OCN) · Tanya.Latorre@pennmedicine.upenn.edu · 215-629-6874Contact: Principal Investigator (Stefan Barta, MD)The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Raphael Steiner, MD) · cr_study_registration@mdanderson.org · 713-792-7734Contact: Principal Investigator (Raphael Steiner, MD)
מובילי המחקר
Ariela Noy, MD
Principal Investigator
Memorial Sloan Kettering Cancer Center